Article Information
History
- March 12, 2021.
Article Versions
- Version 1 (February 18, 2021 - 01:47).
- You are viewing Version 2, the most recent version of this article.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC-ND 4.0 International license.
Author Information
- Wilfredo F. Garcia-Beltran1,2,3,
- Evan C. Lam1,4,
- Kerri St. Denis1,4,
- Adam D. Nitido4,
- Zeidy H. Garcia4,
- Blake M. Hauser4,
- Jared Feldman4,
- Maia N. Pavlovic5,
- David J. Gregory5,6,
- Mark C. Poznansky5,7,
- Alex Sigal8,9,10,
- Aaron G. Schmidt4,
- A. John Iafrate2,
- Vivek Naranbhai7,11,12 and
- Alejandro B. Balazs4,*
- 2Department of Pathology, Massachusetts General Hospital, Boston, MA, 02114, USA
- 3Department of Pathology, Brigham and Women’s Hospital, Boston, MA, 02115, USA
- 4Ragon Institute of MGH, MIT, and Harvard, Cambridge, MA, 02139, USA
- 5Vaccine and Immunotherapy Center, Massachusetts General Hospital, Boston, MA, 02129, USA
- 6Pedriatric Infectious Disease, Massachusetts General Hospital for Children, Boston, MA 02114, USA
- 7Department of Medicine, Massachusetts General Hospital, Boston, MA, 02114, USA
- 8Africa Health Research Institute, Durban, 4001, South Africa
- 9School of Laboratory Medicine and Medical Sciences, University of KwaZulu-Natal, Durban, 4041 South Africa
- 10Max Planck Institute for Infection Biology, Berlin, 10117, Germany
- 11Dana-Farber Cancer Institute, Boston, MA, 02215, USA
- 12Center for the AIDS Programme of Research in South Africa, Durban, 4001, South Africa
- ↵*Lead contact; correspondence: abalazs{at}mgh.harvard.edu
↵1 These authors contributed equally
Posted March 12, 2021.
Multiple SARS-CoV-2 variants escape neutralization by vaccine-induced humoral immunity
